PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Yibing Lu

Second Affiliated Hospital of Nanjing Medical University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)

Diabetes Therapy

This is a design and baseline characteristics report of an ongoing Phase 3 trial with no efficacy or safety results reported; it describes the study protocol and enrolled population but cannot yet support clinical claims.

PreliminaryPharmacology and Obesity Treatment Isabel M. Kloer Liming Chen

Reported

Sample size306

Mean age at baseline36.9 years

Mean body weight at baseline93.9 kg

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support